Bethany Sensenig, Director at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 10,738 shares at $42.25 ($454K) on 2025-08-14, disclosed to the SEC on 2025-08-18.
Scheduled sale ($454k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.25 | 5,369 | $227K | 50.0% |
| 2 | $42.25 | 5,369 | $227K | 50.0% |
| Total | $42.25 avg | 10,738 | $454K | 100% |
| Filing → |